Henry Ford Health

Henry Ford Health Scholarly Commons
Radiation Oncology Meeting Abstracts

Radiation Oncology

12-1-2022

The Impact of Implementing Hypofractionation Prescription
Regimens and Modernizing Delivery Technique on Treatment
Resources in Breast Radiotherapy
S. Quirk
Kundan Thind
L. Van Dyke
K. Long
T. Phan

See next page for additional authors

Follow this and additional works at: https://scholarlycommons.henryford.com/
radiationoncology_mtgabstracts

Authors
S. Quirk, Kundan Thind, L. Van Dyke, K. Long, T. Phan, P. Grendarova, K. Martell, W. L. Smith, L. Barbera,
and M. Roumeliotis

Volume 114  Number 3S  2022
Abstract 2247 − Table 1
Score

Description

5: Use as-is

Clinically acceptable, could be used for treatment without
change.

4: Minor edits are
not necessary

Stylistic differences, but not clinically important. The
current contours are acceptable.

3: Minors edits
are necessary

Edits are clinically important, but it is more efﬁcient to edit
the automatically generated contours than start from
scratch.

2: Major edits

Edits are required to ensure appropriate treatment and
sufﬁciently signiﬁcant that the user would prefer to start
from scratch.

1: Unusable

The automatically generated contours are unusable.
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Developing Dosiomics Models for the Prediction of
Postoperative Radiotherapy-Induced Esophagitis in
Patients with Non-Small Cell Lung Cancer
Z. Ma,1 B. Liang,1 R. Wei,1 Y. Liu,1 B. Yongxing,1 M. Yuan,1 X. Yang,1
Y. Men,2 J. Wang,1 L. Deng,1 Y.R. Zhai,1 N. Bi,1 L. Wang,1 J. Dai,1 and
Z. Hui2; 1Department of Radiation Oncology, National Cancer Center/
National Clinical Research Center for Cancer/Cancer Hospital, Chinese
Academy of Medical Sciences and Peking Union Medical College, Beijing,
China, 2Department of VIP Medical Services & Radiation Oncology,
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Purpose/Objective(s): Symptomatic postoperative radiotherapy-induced
esophagitis (RE) (Grade≥2) develops in up to 31% of patients undergoing
thoracic radiotherapy, lowering the quality of life and sometimes leading to
treatment interruption, which negatively affects overall survival. We
adopted the common omics and convolutional neural network (CNN)
methods to extract dosiomics features to predict RE in patients with nonsmall cell lung cancer (NSCLC), and compared them with the dosimetric
features-based model.
Materials/Methods: Patients with histologically conﬁrmed pIIIA-N2
NSCLC who underwent resection followed by postoperative radiotherapy from 2011 to 2015 were enrolled. The endpoint was Grade≥2
RE according to Common Terminology Criteria for Adverse Events
(CTCAE v4.0). Dosiomics features were extracted from the 3D dose
distribution within the esophagus using the common omics and convolutional neural network (CNN) methods. The extracted features
were screened using an entropy-based method and further selected
using the minimum redundancy maximum relevance (mRMR)
method. Prediction models were built with machine learning algorithms using these selected features as input. The area under the
curve (AUC), accuracy, sensitivity, speciﬁcity, and F1 score were
used to evaluate the performance of prediction models. The prediction model using dosimetric features as input was also built for
comparison.
Results: A total of 189 patients were eligible. Models were trained and
hyper-tuned on 80% (n = 151) of the dataset and validated on the
remaining 20% (n = 38). In total, 107 and 4096 features were derived
with the common omics and CNN methods, respectively. Four common omics features were selected, including glcm_ClusterShade,

Poster Q and A Sessions e113
shape_MinorAxisLength, ﬁrstorder_Kurtosis, Shape_Flatness. Three
CNN-extracted features were selected, while the features were not
interpretable. Four dosimetric features were selected, including the
maximum dose (Dmax), equivalent uniform dose (EUD), percentages
of esophagus volume receiving >20 Gy (V20), >60 Gy (V60). The
AUC, accuracy, sensitivity, speciﬁcity, F1 score were 0.74, 0.70, 0.70,
0.62, 0.80 for common omics features-based model, and 0.79, 0.77,
0.78, 0.68, 0.85 for CNN-extracted features-based model, and 0.64,
0.58, 0.58, 0.62, 0.70 for dosimetric features-based model,
respectively.
Conclusion: Both dosiomics prediction models outperformed the dosimetric features-based model. The CNN-extracted features were more predictive
but less interpretable than the common omics features.
Author Disclosure: Z. Ma: None. B. Liang: None. R. Wei: None. Y. Liu:
None. B. Yongxing: None. M. Yuan: None. X. Yang: None. Y. Men: None.
J. Wang: None. L. Deng: None. Y. Zhai: None. N. Bi: None. L. Wang:
None. J. Dai: None. Z. Hui: None.
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The Impact of Implementing Hypofractionation
Prescription Regimens and Modernizing Delivery
Technique on Treatment Resources in Breast Radiotherapy
S. Quirk,1 K. Thind,2 L. Van Dyke,3 K. Long,4 T. Phan,1,5 P. Grendarova,1
K. Martell,1,6 W.L. Smith,1 L. Barbera,7 and M. Roumeliotis1; 1University of
Calgary, Calgary, AB, Canada, 2Henry Ford Health Systems, Detroit, MI,
3
Alberta Health Services, Calgary, AB, Canada, 4Department of Radiation
Therapy, Tom Baker Cancer Centre, Calgary, AB, Canada, 5Tom Baker
Cancer Centre, University of Calgary, Calgary, AB, Canada, 6Department of
Radiation Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada,
7
Division of Radiation Oncology, University of Calgary, Tom Baker Cancer
Centre, Calgary, AB, Canada
Purpose/Objective(s): To determine the change in treatment resources
due to the implementation of hypofractionated prescription regimen
Materials/Methods: All patients between January 1, 2012 and December
31, 2021 receiving curative intent breast radiotherapy at a tertiary cancer
center were included. Plan and patient data were extracted from the patient
database with the treatment planning system and direct database
query. Treatment plan categorization was completed using data elements to include only curative intent. Treatment plans for seroma
boost or supraclavicular irradiation were excluded to ensure this analysis did not double-count regional nodal irradiation contribution or
confound boost with hypofractionation. Treatment delivery time is
recorded in the database for each patient treatment delivered. Average
patient treatment time per year was estimated by multiplying the average fractions each year by average time in the same year. The standard
fractionation regimens (95% of patients) are 42.56 Gy in 16, 40 Gy in
16, 27 Gy in 5 (accelerated partial breast irradiation), and 26 Gy in 5
(FAST-Forward). In the analysis, implementation milestones are indicated for new prescription regimens and delivery technique changes
including deep inspiration breath hold (DIBH) for left-sided patient
treatments and daily veriﬁcation imaging.
Results: A total of 6505 patients were included. Table 1 details the total number of patients per year, the average number of fractions treated per patient,
and the average treatment time of each patient plan. The average total fractions per treatment decreased from 17.5 in 2012 to 10.9 in 2021. The average
treatment delivery time increased from 12.9 minutes to 21.4 minutes.
Conclusion: In considering total treatment resources, the interplay
between hypofractionation and modernization delivery techniques is complex. The impact of hypofractionation reduced the average number of fractions but total treatment resources are offset with the implementation of
modern treatment delivery techniques. Hypofractionated prescription regimens reduce the time and travel commitment required of patients on an
individual basis, contributing to person-centered care.
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Year

Patients

Average
fractions
per patient

Average
treatment
time (minutes)

Total treatment
resources
(minutes)

Patients
treated in
DIBH (%)

2012

537

17.5

12.9

225.8

0%

2013

537

17.5

14.1

246.8

10%

DIBH implemented
2014

516

17.4

14.8

256.5

38%

2015

608

17.0

13.8

234.6

37%

0.938§0.078 for lumen, from 0.806§0.086 to 0.879§0.072 for vessel wall,
the total variation in normalized wall index decreased from 0.757§0.181 to
0.586§0.182, and the input-output agreement index increased from 0.523
to 0.556 by the proposed reﬁnement procedure.
Conclusion: This study demonstrates that inconsistency in clinical labels
and physiological limitations can be addressed with an iterative interactive
process with parsimonious modeling, taking advantage of ﬂexibility from
deep networks. The rationale generalizes to other label settings and tasks.
Author Disclosure: H. Zhou: None. J. Xiao: None. Z. Fan: None. D.
Ruan: Research Grant; Varian.

APBI (5-fraction) implemented
2016

627

16.1

15.4

247.9

33%

2017

647

15.6

17.8

277.7

51%

2018

706

15.4

18.5

284.9

45%

2019

732

16.1

18.0

289.8

48%

A Prospective Evaluation of Individualized CONstraints for
Radiation Therapy Planning in Prostate Cancer (ICON-P)
S. SAHA, M. Arunsingh, S. Prasath, A. Balakrishnan, S.J. Kalita,
N. Elavarasan, and I. Mallick; Tata Medical Center, Kolkata, India
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Fast forward (5-fraction)
Daily veriﬁcation imaging
2020

730

14.3

19.7

281.7

46%

2021

865

10.9

21.4

233.3

54%

Author Disclosure: S. Quirk: None. K. Thind: None. L. Van Dyke: None.
K. Long: None. T. Phan: None. P. Grendarova: None. K. Martell: None. W.
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Iterative Reﬁnement to Improve Data Quality and Label
Consistency by Synergizing Parsimony Model Guidance
and Physician Interaction
H. Zhou,1 J. Xiao,2 Z. Fan,2 and D. Ruan1; 1University of California, Los
Angeles, Los Angeles, CA, 2University of Southern California, Los Angeles,
CA
Purpose/Objective(s): Clinical data and labeling are usually noisy and
uncertain. Modeling based on such inconsistent data risks overﬁt and may
generate faulty insight on prominent features and regression relationships.
We hypothesize inter-sample consistency serves as a rational surrogate for
data quality and can be used to guide improvement, in the absence of an
absolute ground-truth. To this end, we aim to synergize a deep-learning
setting and an iterative interactive reﬁnement procedure for label
reﬁnement.
Materials/Methods: We proposed a novel approach by guiding physicianapproved label perturbation with parsimonious deep network modeling.
The proposed procedure alternates between ﬁtting a parsimonious deep
network model to human labels and guiding the human observer to review
the labels to identify ill-ﬁtted examples to perform label reﬁnement when
appropriate. Convergence is claimed when further iteration stops to produce clinically pronounced improvement, as deﬁned from a statistical
equivalence test. To evaluate the efﬁcacy of the reﬁnement, input-output
agreement index (IOAI) based on partial ranking consistency is also calculated. We took as a use case in segmenting the lumen and vessel wall from
MR vessel wall imaging (VWI) from 80 patients with intracranial atherosclerotic disease, on four locations with high likelihood of plaque presence:
the intracranial internal carotid artery, the middle cerebral artery, the intracranial vertebral artery, and the basilar artery. Each segment contained 30
contiguous 2D cross-sectional slices with 0.55 mm slice thickness and
0.10 mm in-plane resolution. A lightweight 2.5D segmentation network
was used as the low-dimensional model, and equivalence criterion was
deﬁned by one-sided superiority threshold of 0.03 in Dice similarity coefﬁcient (DSC) based on reported performance from existing study. Clinical
soundness was further assessed with the variation in normalized wall index
as a quantitative imaging index, expected to low if segmented structures
were piecewise smooth conforming to clinical insight.
Results: 5-fold cross validation based on the 80*4*30 slice samples showed
enhanced modeling performance and better conformality to clinical insight
with the ﬁnal labels. In this use case, DSC improved from 0.893§0.108 to

Purpose/Objective(s): Present planning practices for radiation therapy
are based on generic dose-constraints for organs-at-risk (OAR) extrapolated from those deﬁned in the QUANTEC guidance. We have developed a
web-based dashboard to determine individualized dose constraints based
on summary estimates of achieved doses in prior approved plans in prostate cancer. In this study, we prospectively evaluated the feasibility and
improvements achieved in doses to OARs with this approach.
Materials/Methods: A set of 24 cases previously planned using generic
constraints to a dose of 60 Gy in 20 fractions was de-identiﬁed and
replanned using individualized constraints derived from summary statistics
of a subset of cases with similar target, OAR and overlap volumes from a
reference library of 94 approved plans on a web-based dashboard. From
the similar case subset for each study patient, the 25th and 50th percentile
of achieved V59 Gy, V56 Gy, V53 Gy, V47 Gy, V40 Gy for the rectum and
bladder and V57 Gy for the planning target volume (PTV) were deﬁned as
the ideal and acceptable set of individualized dose-constraints. The goal
was to assess the improvement in mean doses and the speciﬁed dose volumes. Planners were blinded to the prior achieved doses and penalties.
Sample size estimation was based on an estimated 3 percentage point
improvement in V53 Gy for rectum and bladder with a paired evaluation
using Wilcoxon sign-rank test. Python v3.7 was used for creating the dashboard and statistical comparisons.
Results: The differences in reference and replanned cases using individualized dose constraints are charted in table 1. There was a numerically robust
and statistically signiﬁcant reduction of mean doses and percentage volumes of all the discrete dose points for both bladder and rectum, including
a 4% and 6.8% reduction in the primary endpoint of V53 Gy. All the plans
generated had a D95 of at least 95% for the PTV.
Conclusion: Treatment planning based on individualized dose constraints
is feasible and leads to improvement at clinically important dose volumes
in prostate cancer treatment planning.
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Bladder
Reference
Plan
(Generic
Doseconstraints)

Rectum

Study plan
(Individualized
doseconstraints)
Improvement

Reference
Plan (Generic
dose
constraints)

Study Plan
(Individualized
doseconstraints)
Improvement

Mean Dose 37.62 Gy

30.07 Gy

7.55 Gy (p value
0.000003)

38.72 Gy

33.16 Gy

5.55 Gy (p
value
0.002)

V59 Gy

5.91%

4.91%

1% (p value 0.004) 7.11%

2.49%

4.63% (p value
0.00001)

V56 Gy

9.77%

7.27%

2.5% (p value
0.004)

13.2%

8.06%

5.14% (p value
0.00003)

V53 Gy

13.03%

9.01%

4.02% (p value
0.002)

17.94%

11.1%

6.84% (p value
0.000008)

V47 Gy

21.09%

12.77%

8.32% (p value
0.0002)

27.74%

16.34%

11.39% (p
value
0.00003)
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